Cargando…
461 A review of cutaneous lymphoma outcomes during COVID-19 pandemic at Columbia University
Autores principales: | Garcia-Saleem, T., Stonesifer, C., Geskin, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053933/ http://dx.doi.org/10.1016/j.jid.2021.02.484 |
Ejemplares similares
-
Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience
por: GARCIA-SALEEM, Tiffany J., et al.
Publicado: (2021) -
28665 Cutaneous T-cell lymphoma (CTCL) outcomes during COVID-19
por: Garcia-Saleem, Tiffany J., et al.
Publicado: (2021) -
441 Cutaneous findings in COVID-19 patients hospitalized at a large urban academic medical center
por: Chand, S., et al.
Publicado: (2021) -
International Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of CTCL outcomes during COVID-19
por: Geskin, Larisa J, et al.
Publicado: (2021) -
International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study
por: Geskin, Larisa J., et al.
Publicado: (2023)